Insiders Theraclion

Equities

ALTHE

FR0010120402

Market Closed - Euronext Paris Other stock markets 11:35:11 2024-07-03 am EDT			5-day change	1st Jan Change
0.344 ^EUR	+0.29%		-2.27%	-11.34%

Jun. 24	Sonovein FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule	CI
Jun. 07	Theraclion: scientific publication hailed by stock market	CF

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Theraclion Names CEO	23-05-26	MT
Theraclion Appoints Martin Deterre as CEO	23-05-25	CI
France's Theraclion Appoints New Chairman	22-01-24	MT
Yann Duchesne Appoints New Executive Chairman to Lead Major Shift in Theraclion’s Strategy	22-01-24	CI
Theraclion Appoints Mehdi El Glaoui to Its Board of Directors	21-06-22	CI
Theraclion SA Announces Executive Changes	20-04-28	CI
Theraclion : Christopher S. Bödtker appointed Chairman of Theraclion	20-04-28	BU
Theraclion announces the reinforcement of its Board of Directors with the nomination of a new Non-Executive Director: Mister Renaud Saleur	18-02-07	BU
Mister Renaud Saleur Joins Theraclion to its Board of Directors on February 1, 2018	18-02-07	CI
Theraclion Appoints Laurence Aucoin as Vice President Operations	16-06-16	CI
Theraclion, S.A.S. Announces Board Changes	16-05-18	CI
Theraclion Hires Dennis Guo as Business Development Director for Asia	15-04-15	CI
Theraclion Appoints Michael Leach as Vice-President UK & Northern Europe	14-12-15	CI
THERACLION Announces Executive Changes	14-11-24	CI
Theraclion, S.A.S. Announces Management Changes	14-09-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer